Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Sheboygan, Wisconsin 25 trials found
New Search
Filter
Trial Phase
Study Type
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
PHASE2INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
PHASE2INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
PHASE3INTERVENTIONAL Berkeley, California +4 more
RECRUITING
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
PHASE3INTERVENTIONAL Bakersfield, California +4 more
RECRUITING
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
PHASE2, PHASE3INTERVENTIONAL Irvine, California +4 more
RECRUITING
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Molecular Genetics Studies of Cancer Patients and Their Relatives
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type